ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

No Cancer Letter For Next Two Weeks

August 19, 1994

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985